LACRISERT Drug Patent Profile
✉ Email this page to a colleague
When do Lacrisert patents expire, and when can generic versions of Lacrisert launch?
Lacrisert is a drug marketed by Bausch And Lomb Inc and is included in one NDA.
The generic ingredient in LACRISERT is hydroxypropyl cellulose. There are forty-one drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the hydroxypropyl cellulose profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LACRISERT?
- What are the global sales for LACRISERT?
- What is Average Wholesale Price for LACRISERT?
Summary for LACRISERT
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 30 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for LACRISERT |
What excipients (inactive ingredients) are in LACRISERT? | LACRISERT excipients list |
DailyMed Link: | LACRISERT at DailyMed |
![LACRISERT drug patent expirations Drug patent expirations by year for LACRISERT](/p/graph/s/t/LACRISERT-patent-expirations.png)
![Drug Prices for LACRISERT](/p/graph/drug-price/LACRISERT.png)
Pharmacology for LACRISERT
Drug Class | Demulcent |
Mechanism of Action | Demulcent Activity |
US Patents and Regulatory Information for LACRISERT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bausch And Lomb Inc | LACRISERT | hydroxypropyl cellulose | INSERT;OPHTHALMIC | 018771-001 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |